Global Trade Alert
Global Trade Alert

Back to state act

Norway: Introduction of export notification requirement on dabigatran etexilate due to anticipated shortages following the COVID-19 outbreak

Description

On 20 March 2020, the Norwegian Medicines Agency introduced a notification requirement on exports of dabigatran etexilate due to anticipated shortages following the COVID-19 outbreak. More specificall...

Sign in to see full description

Intervention Details

Intervention Type

Export licensing requirement

MAST Chapter

P: Export-related measures (incl. subsidies)

Implementation date

20 Mar 2020

Revocation date

15 Jun 2022

Implementation level

National

Affected flow

Outward

Announced as temporary

Yes

Eligible firms

all

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 2 products

Threads

See all

This intervention is not part of any Thread yet.